Get the Stockscreener App
17.84
0.89%
-0.16
Si Bone Inc stock is traded at $17.84, with a volume of 621.37K.
It is down -0.89% in the last 24 hours and up +3.18% over the past month.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$18.00
Open:
$18.14
24h Volume:
621.37K
Relative Volume:
2.00
Market Cap:
$748.18M
Revenue:
$150.71M
Net Income/Loss:
$-40.85M
P/E Ratio:
-17.66
EPS:
-1.01
Net Cash Flow:
$-25.98M
1W Performance:
+8.85%
1M Performance:
+3.18%
6M Performance:
+18.22%
1Y Performance:
-12.07%
1-Day Range:
$17.50
$18.30
1-Week Range:
$16.17
$18.45
52-Week Range:
$11.70
$20.74
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
17.84 | 748.18M | 150.71M | -40.85M | -25.98M | -1.01 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
Si-Bone president Anthony J. Recupero sells $160,732 in stock By Investing.com - Investing.com Australia
Si-Bone president Anthony J. Recupero sells $160,732 in stock - Investing.com India
SI-BONE Executives Sell Shares to Cover Tax Obligations - TradingView
Bruker Appoints Laura Francis to its Board of Directors - Business Wire
SI-BONE (NASDAQ:SIBN) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
SI-BONE Insiders Sell US$1.0m Of Stock, Possibly Signalling Caution - Simply Wall St
SI-BONE (SIBN) Projected to Post Earnings on Monday - MarketBeat
Si-Bone (SIBN) Expected to Beat Earnings Estimates: Should You Buy? - Nasdaq
SI-BONE (NASDAQ:SIBN) vs. Lucid Diagnostics (NASDAQ:LUCD) Head to Head Survey - Defense World
SI-BONE, Inc. (NASDAQ:SIBN) Receives $23.00 Consensus Target Price from Analysts - MarketBeat
SG Americas Securities LLC Sells 5,178 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
Si-Bone director Jeffrey W. Dunn sells $5,562 in common stock - MSN
SI-BONE (NASDAQ:SIBN) and Stevanato Group (NYSE:STVN) Critical Survey - Defense World
Spotify (SPOT) Q4 Earnings Miss Estimates - Yahoo Finance
SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025 - The Manila Times
SI-BONE, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 - Nasdaq
SI-BONE Q4 Earnings: Key Financial Results Coming February 24What's Next for Medical Device Leader? - StockTitan
Indian banks' loan growth drops for sixth month in December as tighter lending curbs weigh - Yahoo Finance
(SIBN) On The My Stocks Page - Stock Traders Daily
FY2024 EPS Estimates for SI-BONE Raised by Cantor Fitzgerald - Defense World
SI-BONE FY2024 EPS Forecast Increased by Cantor Fitzgerald - MarketBeat
JPMorgan Chase & Co. Increases Holdings in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
JPMorgan Chase & Co. Purchases 22,732 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - MarketBeat
SI-BONE, Inc. (NASDAQ:SIBN) Looks Just Right With A 26% Price Jump - Simply Wall St
SI-Bone price target raised to $20 from $19 at Needham - Yahoo Finance
TSMC Leads Pre-Market Gains After Record Q4 Earnings; Other Stocks See Volatility – Coin Trading - HPBL
Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Brokerages Set SI-BONE, Inc. (NASDAQ:SIBN) Target Price at $23.00 - Defense World
SI-BONE (NASDAQ:SIBN) Trading Down 2.6%Time to Sell? - MarketBeat
SI-BONE Inc (SIBN) Stock Price Down 7.33% on Jan 14 - GuruFocus.com
SI-BONE Q4 2024 revenue increases 26% - Medical Buyer
SI-BONE (NASDAQ:SIBN) adds US$88m to market cap in the past 7 days, though investors from three years ago are still down 28% - Simply Wall St
SI-BONE (NASDAQ:SIBN) Given “Buy” Rating at Needham & Company LLC - Defense World
SI-BONE Shares Rise 19% on Expected Higher 4Q, Full-Year Revenue - MarketWatch
SI-BONE (NASDAQ:SIBN) Trading 8.1% HigherHere's Why - MarketBeat
SI-BONE announces Q4 preliminary worldwide revenue between $48.8$49M - MSN
Needham & Company LLC Reaffirms Buy Rating for SI-BONE (NASDAQ:SIBN) - MarketBeat
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday - Benzinga
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024 - The Manila Times
SI-BONE Hits Record Q4 Revenue with 26% Growth, Achieves EBITDA Profitability Milestone - StockTitan
Barclays PLC Buys 63,402 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - MarketBeat
Barclays PLC Grows Position in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
SI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Harbor Capital Advisors Inc. - MarketBeat
(SIBN) Proactive Strategies - Stock Traders Daily
Si-Bone's president of commercial ops sells $51,014 in stock By Investing.com - Investing.com South Africa
Si-Bone CFO Anshul Maheshwari sells $73,802 in stock By Investing.com - Investing.com Australia
SI-BONE, Inc. (NASDAQ:SIBN) Insider Anthony J. Recupero Sells 3,670 Shares - MarketBeat
SI-BONE, Inc. (NASDAQ:SIBN) CFO Anshul Maheshwari Sells 5,304 Shares - MarketBeat
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Si Bone Inc Stock (SIBN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Maheshwari Anshul | Chief Financial Officer |
Feb 18 '25 |
Sale |
16.86 |
11,180 |
188,518 |
273,604 |
| RECUPERO ANTHONY J | President, Commercial Ops |
Feb 18 '25 |
Sale |
16.86 |
9,531 |
160,732 |
287,866 |
| DUNN JEFFREY W | Director |
Feb 18 '25 |
Sale |
16.77 |
1,619 |
27,152 |
15,191 |
| DUNN JEFFREY W | Director |
Feb 03 '25 |
Sale |
16.51 |
337 |
5,562 |
17,290 |
| RECUPERO ANTHONY J | President, Commercial Ops |
Jan 02 '25 |
Sale |
13.90 |
3,670 |
51,014 |
222,814 |
| Maheshwari Anshul | Chief Financial Officer |
Jan 02 '25 |
Sale |
13.91 |
5,304 |
73,802 |
189,319 |
| DUNN JEFFREY W | Director |
Nov 18 '24 |
Sale |
12.43 |
1,609 |
20,001 |
20,431 |
| RECUPERO ANTHONY J | President, Commercial Ops |
Nov 18 '24 |
Sale |
12.60 |
3,937 |
49,609 |
228,554 |
| RECUPERO ANTHONY J | President, Commercial Ops |
Nov 19 '24 |
Sale |
12.17 |
2,070 |
25,195 |
226,484 |
| Maheshwari Anshul | Chief Financial Officer |
Nov 18 '24 |
Sale |
12.68 |
2,439 |
30,937 |
194,623 |
1.16%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):